Fertility Drug and Surgery Market to Reach USD 8.8 Billion by 2034

Pune, India, November 7, 2025 - The Global Fertility Drug and Surgery Market is projected to grow from USD 5.1 billion in 2024 to approximately USD 8.8 billion by 2034, registering a CAGR of 5.9% during the forecast period (2025-2034), according to Exactitude Consultancy. The market's expansion is primarily driven by delayed family planning, hormonal imbalances, lifestyle-related infertility, and increasing acceptance of fertility treatments among both men and women.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/49054

Key Takeaways
• Market Size (2024): USD 5.1 Billion
• Forecast (2034): USD 8.8 Billion
• CAGR (2025-2034): 5.9%
• Key Segments: Treatment Type, Drug Type, Procedure, End User, and Region
• Leading Companies: Merck KGaA, Ferring Pharmaceuticals, Bayer AG, Abbott Laboratories, Novartis AG, Organon & Co., Thermo Fisher Scientific Inc., and Cook Medical.

Market Story
Infertility has emerged as a global health concern affecting millions of couples worldwide. According to WHO, one in six adults experiences infertility at some stage of life, underscoring the growing need for effective fertility drugs and assisted surgical interventions.

Fertility drugs such as gonadotropins, clomiphene citrate, and aromatase inhibitors remain the cornerstone of treatment, promoting ovulation and improving reproductive outcomes. Meanwhile, advancements in minimally invasive surgical techniques-including laparoscopy for tubal corrections and endometriosis management-are enhancing success rates for couples undergoing fertility treatment.

The integration of AI-based embryo selection, cryopreservation techniques, and next-generation IVF protocols is also reshaping clinical outcomes. Increasing insurance coverage for fertility procedures and government-backed initiatives supporting reproductive health are further propelling the market forward.

Market Segmentation
By Treatment Type:
Fertility Drugs, Fertility Surgeries

By Drug Type:
Gonadotropins, Clomiphene Citrate, Aromatase Inhibitors, Dopamine Agonists, Others

By Procedure:
In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), Tubal Ligation Reversal, Laparoscopy, Hysteroscopy, Others

By End User:
Fertility Clinics, Hospitals, Research Centers, Homecare Settings

By Region:
North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Explore Full Report here: https://exactitudeconsultancy.com/reports/49054/fertility-drug-surgery-market

Recent Developments
• Merck KGaA launched Pergoveris® Pen for controlled ovarian stimulation, combining FSH and LH in a single injection system.
• Ferring Pharmaceuticals introduced Rekovelle®, a recombinant human FSH personalized for patient-specific dosing.
• Cook Medical expanded its fertility surgery product portfolio with advanced laparoscopic instruments.
• Organon & Co. strengthened its fertility therapy pipeline through strategic collaborations with ART centers.
• Thermo Fisher Scientific developed advanced culture media formulations for improved embryo development in IVF.

Expert Insight
"Global fertility patterns are shifting, and technology is bridging the biological gap. With innovations in personalized hormonal therapy and microsurgical precision, fertility treatment is becoming safer, more accessible, and increasingly effective,"
- Lead Reproductive Health Analyst, Exactitude Consultancy.

Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=4905

Market Drivers
• Rising Infertility Rates: Linked to stress, lifestyle changes, obesity, and environmental factors.
• Technological Advancements: Integration of AI and precision medicine in IVF and fertility surgery.
• Increased Awareness: Growing social acceptance and awareness campaigns encouraging fertility treatment.
• Expanding Healthcare Access: Fertility clinics expanding across emerging economies.

Forecast & Regional Insights
North America dominates the global fertility drug and surgery market, accounting for over 39% of total revenue in 2024, supported by high treatment affordability, advanced ART infrastructure, and early adoption of innovative therapies. Europe follows with widespread IVF availability under public health programs. The Asia-Pacific region is expected to register the fastest CAGR of 6.7%, driven by rising infertility rates, increased female workforce participation, and growing demand for affordable fertility treatment in India, China, and Japan.

Conclusion
The fertility drug and surgery market is on a growth trajectory powered by scientific innovation and evolving societal norms. As fertility clinics embrace automation, precision dosing, and AI-driven treatment planning, accessibility and success rates in reproductive care are expected to reach unprecedented levels over the coming decade.

This report is also available in the following languages : Japanese (不妊治療薬手術市場), Korean (불임 치료 약물 수술 시장), Chinese (生育药物手术市场), French (Marché des médicaments et de la chirurgie de la fertilité), German (Markt für Fruchtbarkeitsbehandlungen mit Medikamenten), and Italian (Mercato della chirurgia farmacologica per la fertilità), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @https://exactitudeconsultancy.com/reports/49054/fertility-drug-surgery-market#request-a-sample

Related Reports

Alcohol Breathalyzer and Drug Testing Equipment Market
https://exactitudeconsultancy.com/reports/75979/alcohol-breathalyzer-and-drug-testing-equipment-market

Disposable Syringes Market
https://exactitudeconsultancy.com/reports/76039/disposable-syringes-market

Next-Generation Sequencing (NGS) Market
https://exactitudeconsultancy.com/reports/76042/next-generation-sequencing-ngs-market

Acute Radiation Syndrome Market
https://exactitudeconsultancy.com/reports/76062/acute-radiation-syndrome-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.